The Food and Drug Administration said there has been a significant increase in safety issues concerning Philips DreamStation 2 continuous positive airway pressure (CPAP) breathing machines, which are used to treat sleep apnea.
Between 1 August and 15 November, the FDA said it had received 270 medical device reports (MDRs) associated with thermal...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?